PG12-23/PCUK_/Prostate Cancer UK/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2013	1
2014	5
2015	1
2016	5
2017	1
2019	1
2020	1
2025	0

1

Falasca M, Casari I, Maffucci T. Falasca M, et al. J Natl Cancer Inst. 2014 Sep 10;106(9):dju238. doi: 10.1093/jnci/dju238. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25210199 Review.

2

Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts.

Falasca M, Maffucci T. Falasca M, et al. Front Physiol. 2014 Oct 15;5:391. doi: 10.3389/fphys.2014.00391. eCollection 2014. Front Physiol. 2014. PMID: 25360116 Free PMC article. Review.

3

Role of the lysophosphatidylinositol/GPR55 axis in cancer.

Falasca M, Ferro R. Falasca M, et al. Adv Biol Regul. 2016 Jan;60:88-93. doi: 10.1016/j.jbior.2015.10.003. Epub 2015 Oct 28. Adv Biol Regul. 2016. PMID: 26588872 Review.

4

Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy.

Emmanouilidi A, Casari I, Gokcen Akkaya B, Maffucci T, Furic L, Guffanti F, Broggini M, Chen X, Maxuitenko YY, Keeton AB, Piazza GA, Linton KJ, Falasca M. Emmanouilidi A, et al. Cancers (Basel). 2020 Jul 23;12(8):2022. doi: 10.3390/cancers12082022. Cancers (Basel). 2020. PMID: 32718079 Free PMC article.

5

Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors.

Ruban EL, Ferro R, Arifin SA, Falasca M. Ruban EL, et al. Biochem Soc Trans. 2014 Oct;42(5):1372-7. doi: 10.1042/BST20140151. Biochem Soc Trans. 2014. PMID: 25233417 Review.

6

Role of phospholipase C in cell invasion and metastasis.

Lattanzio R, Piantelli M, Falasca M. Lattanzio R, et al. Adv Biol Regul. 2013 Sep;53(3):309-18. doi: 10.1016/j.jbior.2013.07.006. Epub 2013 Jul 18. Adv Biol Regul. 2013. PMID: 23925006 Review.

7

Class II Phosphoinositide 3-Kinases as Novel Drug Targets.

Falasca M, Hamilton JR, Selvadurai M, Sundaram K, Adamska A, Thompson PE. Falasca M, et al. J Med Chem. 2017 Jan 12;60(1):47-65. doi: 10.1021/acs.jmedchem.6b00963. Epub 2016 Oct 21. J Med Chem. 2017. PMID: 27644332 Review.

8

New insight into the intracellular roles of class II phosphoinositide 3-kinases.

Maffucci T, Falasca M. Maffucci T, et al. Biochem Soc Trans. 2014 Oct;42(5):1378-82. doi: 10.1042/BST20140140. Biochem Soc Trans. 2014. PMID: 25233418 Review.

9

Targeting the adipose tissue to fight prostate cancer.

Paternoster S, Falasca M. Paternoster S, et al. Transl Androl Urol. 2019 Jul;8(Suppl 3):S229-S231. doi: 10.21037/tau.2019.01.13. Transl Androl Urol. 2019. PMID: 31392130 Free PMC article. No abstract available.

10

Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.

Chikh A, Ferro R, Abbott JJ, Piñeiro R, Buus R, Iezzi M, Ricci F, Bergamaschi D, Ostano P, Chiorino G, Lattanzio R, Broggini M, Piantelli M, Maffucci T, Falasca M. Chikh A, et al. Oncotarget. 2016 Apr 5;7(14):18325-45. doi: 10.18632/oncotarget.7761. Oncotarget. 2016. PMID: 26934321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year